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Abstract
Background: Iris tumors are rare in young patients. When an iris lesion occurs in a pediatric patient, it can be
difficult to classify because of the wide spectrum of iris proliferations.
Case presentation: We report on an unusual case of a vascularized iris lesion in a three year old Caucasian patient,
with no symptoms and no visual impairment. We evaluated in a 50-month follow up with non-invasive diagnostic
tools in order to avoid eye biopsy.
Conclusion: We focused attention on the differential diagnoses and underlined the role of non-invasive diagnostic
tools in a child to avoid or postpone the eye biopsy. We performed a review of the literature to identify the best
medical practice in pediatric iris lesions with atypical characteristics.
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Background
In a retrospective case series of 3680 patients, iris
tumors predominantly affected Caucasians (96 %) and
were rare in patients under 20 years of age (12 %) [1].
There is a wide spectrum of iris tumors and there are
few comprehensive series on the full array of clinical
ocular manifestations [1]. Morphologic heterogeneity
among melanocytic proliferations is a common challenge
in the diagnosis of melanoma. In particular, atypical
melanocytic lesions in children, adolescents, and young
adults may be difficult to classify because of a significant
morphologic overlap with melanoma. The clinical differ-
entiation of iris lesions is based upon careful slit lamp
examination and gonioscopy and is confirmed by ocular
imaging with ultrasound biomicroscopy (UBM) and in
some cases, anterior segment optical coherence tomog-
raphy (AS OCT) [2].
The correct diagnosis can be particularly challenging
in younger patients because serial examinations under
anesthesia are required to accurately follow the progres-
sion of the tumor. We report on a 3 year old child in
whom an abrupt onset of an iris mass was noted by his
parents over three weeks.
Case presentation
A three year-old Caucasian male patient was referred to
our clinic in October 2010 for evaluation of a mass on
the iris of his right eye. The lesion was originally noted
approximately 2 months earlier and the parents
observed a progressive increase in its size over the prior
three weeks. (Fig. 1)
The parents did not report any subjective complaint of
the child. Family and medical history were negative.
The patient was orthophoric with normal binocular
visual skills (tracking, convergence, fusion and stereoa-
cuity). His best corrected visual acuity was 10/10 in both
eyes (Tumbling E).
The right eye anterior segment examination revealed
an elevated, solid, slightly vascularized, amelanotic, light
pink mass situated at the 6 clock hour of the iris,
extended for 1 clock hour, without satellite lesions. The
patient’s anterior left eye segment was clear, without cell
and flare, deep, well formed, and did not display iris
heterochromia when compared to the fellow eye. Pupils
were isocoric and the light reflexes were normal.
Because of the young age of the patient, gonioscopic
evaluation of the right eye was not possible.
The patient was referred to Prof Zografos in Lausanne
who is one of the European Referring Centers for eye
neoplastic diseases and evaluated in January 2011, where
he underwent examination under anesthesia. With the
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aid of operating microscope and a portable slit lamp,
they found a vascularized lesion that seemed to originate
from the superficial iris stroma. The intraocular pressure
was normal in both eyes. The intraoperative gonioscopy
revealed a totally open-angle structure without any
involvement of the ciliary body.
The ultrasound biomicroscopy examination showed a
well-defined neoformation localized in the iris stroma,
not occupying the iris corneal angle, not involving the
ciliary body and with low reflectivity. The surrounding
iris stroma was thin. (Figs. 2, 3 and 4)
Solid tumors of the iris include melanocytic and non-
melanocytic lesions.
Melanocytic iris tumors comprise a broad spectrum of
lesions ranging from benign nevi to aggressive malignant
melanomas. Morphologic heterogeneity among melano-
cytic proliferations is a common challenge in the diagno-
sis of melanoma [1–3].
The nonmelanocityc lesions are relatively uncommon
and include different categories, such as: lacrimal gland
choristomas of the iris [4], hemangiomas, neurofibromas,
leiomyomas, adenomas and adenocarcinomas [5], xantho-
matous lesions, metastatic, lymphoid and leukemic lesions
and non-neoplastic mimickers, such us iris cysts or
inflammatory lesions [2, 3].
Considering the age of the patient, the growth of the
lesion and the morphologic and ultrasound characteris-
tics we were oriented towards small amelanotic iris
melanoma, mesoectodermal leyomioma, choristoma or
xantoma/xantogranuloma.
A retrospective multicentral study in ophthalmic
oncology, demonstrated that most iris melanomas are
located in the inferior iris (79.2 %); they are tipically
unifocal (88 %). Tumor color is predominantly brown
(65 %), followed by amelanotic (9.9 %) and multicolored
Fig. 1 Two consecutive pictures of the patient before and after the
first presentation of lesion: The onset of the iris lesion. The two
pictures were taken respectively on October 2009 (first row, no
evidence of the lesion) and December 2009 (second row, first
appearance of the lesion)
Fig. 2 slit lamp anterior segment photography in November 2012:
the pictures demonstrates the presence of an iris vascularized
pink lesion
Fig. 3 slit lamp anterior segment photography on April 2014: the
picture demonstrates the stability of dimension and vascularization
throughout months
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(6.9 %). Intrinsic tumor vessels are present in 56 % of
cases [6]. We found many of these features in this case,
which imposed a strict follow up of the patient.
Mesectodermal leiomyoma is a rare tumor originating
from smooth muscle, having both muscular and neural
differentiation. The first case was reported in 1977, and
so far 24 cases have been reported. It should be consid-
ered in the differential diagnosis of an amelanotic melan-
oma, especially in young people [3].
Choristoma is a non-neoplastic, mass-forming lesion
containing ectopic or heterologous elements. Although
choristomas most commonly involve the epibulbar area,
they can affect many areas of the eye and orbit, and
often affect more than one area. Choristomas may be
associated with coloboma, Goldenhar syndrome or
epidermal nevus syndromes; those associated with the
latter are often bilateral and extensive. Choristomas are
occasionally familial [7].
Most xanthoma/xanthogranuloma of the iris occurs in
children. Approximately one half of patients with ocular
involvement have skin lesions [2].
The patient underwent follow-up visits every 6 months
for two years and was followed annually thereafter.
Tumor stability was assessed by serial UBM and slit
lamp photos examinations.
Several features were assessed with the UBM examin-
ation: 1) lesion thickness, 2) internal structure (regular
and irregular) and 3) internal reflectivity.
A substantial growth was defined if the iris lesion showed
an increase in basal diameter and/or thickness (assessed by
UBM) of ≥20 % from the previous visit (6 months earlier),
or if there is progressive increase in a basal diameter or
thickness over 2 or more consecutive visits [8, 9].
The absence of hyphema, seeding of the lesion and
intraocular pressure were monitored.
During the 50- month follow up, the lesion did not in-
crease in size, invade iris stroma, nor involve the angle
structures. We shared photographs and clinical informa-
tion with Lausanne Clinic experts in iris tumors, who
confirmed our decision to observe.
During the last visit in February 2015, AS OCT and
Scheimpflug camera Image were acquired. (Fig. 5)
Conclusions
Most of iris tumors in children are cystic, but iris solid
neoformations represent a real challenge for the oph-
thalmologist especially in younger patients. Obtaining
reliable images can be challenging, the number of cases
is small even in tertiary centers and the presentation is
polymorphous and variable. Furthermore even benign
melanocytic lesions tend to have a higher rate of growth
into melanoma, especially if they involve the inferior
quadrants [10].
The case we present has some characteristics of a
malignant lesion: it presented with an abrupt growth
documented by the parents’ photographs, has an inferior
location, is nodular, solitary and vascularized. The size
(1,9 mm), the absence of iris infiltration, pupillary distor-
tion, ectropion uveae or glaucoma were suggestive of a
benign lesion.
The choice was to proceed with sequential observation
of the lesion without proceeding to more invasive proce-
dures because most iris tumors can be diagnosed using
clinical and historical criteria without the need for cyto-
logic or pathologic verification [3, 4]. Rarely is a clinical
biopsy necessary to confirm the diagnosis of uveal mel-
anoma. The Collaborative Ocular Melanoma Study re-
ported >99 % diagnostic accuracy for eyes with typical
features that were enucleated [11].
Fine-needle aspiration biopsy (FNAB) should be
reserved for iris tumors in which a diagnosis cannot be
obtained and further observation of the lesion could be
dangerous to the patient, the eye, or the visual acuity. In
addition, some iris tumors are better served with local
resection rather than FNAB, depending on tumor loca-
tion and size, tumor friability, feeder or intrinsic vessels,
and the risk of potential seeding of tumor onto the iris
surface or anterior chamber [12, 13].
Photographic and UBM documentation of the clinical
features can be of great help in diagnosis and follow up of
solid iris tumors. It is extremely important to have high
quality images in order to document the surface charac-
teristics of the tumor. Serial photographs can also be
important to document presence of hyphema, significant
vascularization or changes in the pigmentation of the
lesion. Tumor size, boundaries, thickness and changes in
the internal structure can be followed up by UBM. We
did not document the lesion with OCT because at the
time of diagnosis, the child was too young to reliably
Fig. 4 anterior segment slit lamp photography on February 2015 :
the picture demonstrates the stability of dimension and
vascularization throughout months
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undergo the examination. We recently acquired AS-OCT
images because we believe that this less invasive technique
can help to further follow the patient, although for anter-
ior segment tumors, UBM offers better visualization of
the posterior margin and provides overall better images
for entire tumor configuration [14, 15].
Although we were not able to establish a clear-cut
diagnosis of the lesion, our approach helped us to
exclude a potentially sight threatening lesion. Further
follow-up is warranted in such a case, although the
timing of the visits may be determined according to the
evolution of the lesion. We planned annual follow up
visit from now on.
Abbreviations
AS-OCT, anterior segment optical coherence tomography; FNAB, fine needle
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